Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Incannex Healthcare Inc. entered into Placement Agent Agreement with Curvature Securities, LLC (effective 2026-03-12).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Curvature Securities, LLC
- Effective
- 2026-03-12
Exact text from the filing
On March 12, 2026, the Company entered into a placement agency agreement (the “Placement Agent Agreement”) with Curvature Securities, LLC (“Curvature” or the “Placement Agent”) pursuant to which the Company engaged Curvature as the sole placement agent in connection with the Offering.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Incannex Healthcare Inc. entered into Securities Purchase Agreement with certain institutional investors valued at approximately $10 million (effective 2026-03-12).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain institutional investors
- Value
- approximately $10 million
- Effective
- 2026-03-12
Exact text from the filing
On March 12, 2026, Incannex Healthcare Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “Offering”) by the Company directly to the Investors (the “Registered Offering”), (i) an aggregate of 1,997,285 shares of its common stock, par value $0.0001 per share (such shares, the “Shares”; such stock, the “Common Stock”), (ii) pre-funded warrants to purchase up to 2,715 shares of its Common Stock (the “Pre-Funded Warrants”), and (iii) common stock warrants to purchase up to 2,000,000 shares of its common stock (the “Common Warrants”) at a combined purchase price of $5.0 per Share and accompanying Common Warrant, or $4.9999 per Pre-Funded Warrant and accompanying Common Warrant.
View on SEC.gov